Indivior Pharmaceuticals Inc
INDV
Rang in Aktien
#4015
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Aktienkurs
$32.56
Zuletzt synchronisiert: 2026-10-16
Marktkapitalisierung
$4.06B
Veränderung (1 Tag)
-3.15%
Veränderung (1 Jahr)
33.01%
Land
US
Handel Indivior Pharmaceuticals Inc (INDV)
Kategorie
Healthcare
EPS für Indivior Pharmaceuticals Inc (INDV)
EPS zum June 2026 TTM: $2.84
Laut den aktuellen Finanzberichten und dem Aktienkurs von Indivior Pharmaceuticals Inc beträgt das aktuelle EPS des Unternehmens (TTM) $2.84. Am Ende des Jahres 2023 betrug das EPS $0.01 eine Steigerung gegenüber dem EPS von 2022, das $-0.37 betrug.
EPS-Verlauf von Indivior Pharmaceuticals Inc von 2016 bis 2026
EPS am Ende jedes Jahres
| Jahr | EPS | ändert |
|---|---|---|
| 2026 (TTM) | $2.84 | 14,100.00% |
| 2024 | $0.02 | 3.42% |
| 2023 | $0.01 | -103.95% |
| 2022 | $-0.37 | -126.81% |
| 2021 | $1.38 | -227.78% |
| 2020 | $-1.08 | -213.68% |
| 2019 | $0.95 | -47.51% |
| 2018 | $1.81 | 330.95% |
| 2017 | $0.42 | 90.91% |
| 2016 | $0.22 | 0.00% |
EPS für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | EPS | EPS-Differenz | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -80.41% |
IN
|
